Navigation Links
February 2009 Mayo Clinic Women's HealthSource Highlights Diabetes and Heart Disease, Going Vegetarian and Tinnitus
Date:2/4/2009

Diabetes and Heart Disease: Risk Intertwined

ROCHESTER, Minn., Feb. 4 /PRNewswire-USNewswire/ -- Here are highlights from the February issue of Mayo Clinic Women's HealthSource. You may cite this publication as often as you wish. Mayo Clinic Women's HealthSource attribution is required. Reprinting is allowed for a fee. Include the following subscription information as your editorial policies permit: Visit www.bookstore.mayoclinic.com or call toll-free for subscription information, 800-876-8633, extension 9751.

What's the most common long-term complication of diabetes? Problems with the heart and blood vessels, according to the February issue of Mayo Clinic Women's HealthSource.

Cardiovascular diseases, including heart attack and stroke, account for 65 percent of all diabetes-related deaths. People with diabetes are two to four times more likely to have a heart attack than someone without the disease. For a middle-aged person with type 2 diabetes, the risk of a future heart attack is the same as that of someone who's already had a heart attack. Also attention getting: when people with diabetes have heart attacks, they are more serious and more likely to result in death than in adults without diabetes.

People with diabetes are at higher risk of cardiovascular disease because too much blood sugar (glucose) can lead to damage inside blood vessel walls. This damage makes it easier for fatty deposits (plaques) to form in arteries and cause narrowing or blockages that can lead to heart attacks or strokes.

Having diabetes doesn't mean heart disease is inevitable. Optimal control over the ABCs of diabetes, as suggested by the American Diabetes Association, can reduce heart disease risk. The ABCs are:

A1C: The best way to measure blood glucose levels over time i
'/>"/>

SOURCE Mayo Clinic
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Cequent to Present First Proof of Activity of an Oral RNAi Drug in Non-Human Primates at February Keystone Conference
2. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
3. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
4. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
5. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
6. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
7. Romark Initiates Clinical Trial of Alinia(R) for Chronic Hepatitis C in the United States
8. The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma
9. Millennium Initiates Clinical Trial to EVOLVE the Treatment of Patients with Newly Diagnosed Multiple Myeloma
10. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
11. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Md. , Sept. 2, 2015  RegeneRx ... a clinical-stage drug development company focused on tissue ... J.J. Finkelstein , President and Chief Executive Officer, ... & Renshaw Global Investment Conference, sponsored by ... be held September 8-10, 2015 at the St. ...
(Date:9/2/2015)... PAUL, Minn. , Sept. 2, 2015  MGC ... today scheduled a conference call to discuss its financial ... July 31, 2015. The call will be at 4:30 ... will report financial results for the third quarter of ... 10, 2015. Participants can dial (877) ...
(Date:9/2/2015)... YORK , Sept. 2, 2015 Relmada ... novel therapies for the treatment of chronic pain, announced ... meetings at both the FBR Second Annual Healthcare Conference ... as follows: FBR Second Annual Healthcare Conference ... Boston No presentation, investor ...
Breaking Medicine Technology:RegeneRx to Present at Rodman & Renshaw Global Investment Conference 2RegeneRx to Present at Rodman & Renshaw Global Investment Conference 3MGC Diagnostics Corporation to Report Third Quarter Fiscal 2015 Financial Results on Thursday, September 10, 2015 2Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2
... 2007 - Inotek,Pharmaceuticals Corporation announced today the ... the safety of INO-1001,as well as the ... for,cardiac reperfusion injury. The study was conducted ... undergoing,primary percutaneous coronary intervention. The presentation was,made ...
... 2007--A new study shows that as rates,of diabetes ... disease (CVD) linked to diabetes has also,increased. , ... to,prevent diabetes and to aggressively treat and control ... the investigators,from the long-standing Framingham Heart Study, a ...
Cached Medicine Technology:Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 2Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 3Inotek Pharmaceuticals Announces Presentation of Phase 2 Clinical,Data for INO-1001 at ACC Demonstrating PARP Inhibition and,Anti-inflammatory Activity in Plasma of Patients Undergoing Primary,Percutaneous Coronary Intervention 4Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 2Increasing Proportion of Cardiovascular Disease Due to Diabetes,Over the Last 50 Years 3
(Date:9/2/2015)... ... September 02, 2015 , ... Ovarian cancer continues to be the deadliest ... getting ovarian cancer in her lifetime is approximately 1 in 75. This year it ... and 14,000 will die. , There is no test to detect ovarian cancer. ...
(Date:9/2/2015)... (PRWEB) , ... September 02, 2015 , ... ... PHYTOMER, the pioneer in marine cosmetics introduces PIONNIÈRE XMF Perfection Youth Rich ... new cream combines breakthrough biotechnological anti-aging power with a lipid-replenishing marine oil for ...
(Date:9/2/2015)... , ... September 02, 2015 , ... ... business services, has been named to the Inc. 5000 List, an independent ... publishing this list for 34 years, and this achievement puts Canopy in rarefied ...
(Date:9/2/2015)... ... September 02, 2015 , ... Traveling to the Caribbean can be an amazing ... and fauna. , Lifestyle Holidays Vacation Club knows that Puerto Plata ... experience that much better, Lifestyle Holidays Vacation Club has put together its list of ...
(Date:9/1/2015)... FL (PRWEB) , ... September 01, 2015 , ... September ... about this disease that affects more than 233,000 men each year in the United ... is the most common non-skin cancer in America, affecting 1 in 7 men. One ...
Breaking Medicine News(10 mins):Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 2Health News:National Ovarian Cancer Coalition's DFW Chapter Features First Annual Teal Lights Display This Friday, September 4th, "National Wear Teal Day" 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 2Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 3Health News:Phytomer announces PIONNIÈRE XMF Perfection Youth Rich Cream 4Health News:Canopy Partners Named to 2015 Inc. 5000 Fastest Growing Companies List 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 2Health News:Lifestyle Holidays Vacation Club Lists 3 Things to Consider When On a Puerto Plata Vacation 3Health News:September is Prostate Cancer Awareness Month 2Health News:September is Prostate Cancer Awareness Month 3
... in BJOG: An International Journal of Obstetrics and Gynaecology ... and placental abruption during the subsequent pregnancies of ... ,Placental praevia is defined as the implantation of ... the cervix. Placenta abruption is the premature separation of ...
... a campaign to encourage Hispanics to eat healthier food, ... U.S. Hispanics increased from 11.6% in 1991 to 23.7% ... obese and two times more likely to have diabetes ... ,LNC's campaign features a "Latin American ...
... their lives to work- related cancers and heart attacks can ... laws state that they no longer need to prove ... due the dead workers family. , The ... will be presumed to have been work-related when contracted by ...
... the US. A Defence Department panel has warned that ... serious challenge on two fronts. ,One, soldiers are ... at the current level of staffing and funds, the military ... necessary statement. ,In a damning revelation, the ...
... is no dearth of "anti-aging" products and surgeries in ... women go for them not just to enhance their looks, ... competitive enough in the market place, many observers point out. ... toxin. The toxin blocks the transmission of acetylcholine from the ...
... in 70 schoolchildren, available data says. The question is whether ... joint team of scientists from the King's College London ... up a seven-year study and hope to rope in 480 ... studied are between four and 11 months and already have ...
Cached Medicine News:Health News:Placental Problems in Women Linked With Caesarean Section 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 2Health News:Ontario Grants Fast-Track Compensation Rights for Work-Related Illnesses 3Health News:One Third of US Troops Suffer from Mental Health Problems 2Health News:One Third of US Troops Suffer from Mental Health Problems 3Health News:More and More American Women Go for Facelifts to Get Jobs 2Health News:UK Scientists to Undertake Seven Year Study of Peanut Allergy 2
Thesystem combines an exclusive dual light-source design and a versatile sample compartment to provide solid, reliable performance....
Inquire...
The Spex SkinSkan is the only in-vivo, fibre-optic spectrofluorometer designed specifically for skin-fluorescence measurements. It is also ideal for many remote sensing steady-state fluorescence appl...
The unique RF-1501 optical design provides exceptional sensitivity in an incredibly compact instrument....
Medicine Products: